News

EvolveImmune Therapeutics Appoints Jay Fine, Ph.D., as President of Research and Development

Over 30 Years of Leadership in Drug Discovery and Development, Translational Sciences and Biomarker Research in Immunology, Inflammatory Diseases and…

2 years ago

MediWound Announces Positive Results from its U.S. Phase 2 Pharmacology Study of EscharEx for Debridement of Lower Leg Ulcers

EscharEx Showed Safe, Effective and Rapid Debridement in VLUs and DFUsData Demonstrates EscharEx Reduced Wound Size, Biofilm and Bacterial Burden…

2 years ago

Zynerba Pharmaceuticals Announces Panel Presentation and Poster Presentations at the NFXF International Fragile X Conference

DEVON, Pa., July 07, 2022 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid…

2 years ago

RVL Pharmaceuticals plc Announces Preliminary Second Quarter 2022 UPNEEQ® Net Product Sales Results

-- Expects second quarter 2022 preliminary UPNEEQ net product sales of approximately $8.4 million, representing an increase of 42% from…

2 years ago

Asensus Surgical Announces Installation of Senhance Surgical System in the Department of Gynecology at University Hospital Tübingen

This becomes the 6th Senhance Hospital in GermanyRESEARCH TRIANGLE PARK, N.C., July 07, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc.…

2 years ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022

PORTLAND, Maine, July 07, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company…

2 years ago

Immuron Receives European Patent Notification on Drug Composition to Treat Clostridioides difficile Associated Disease

MELBOURNE, Australia, July 07, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on…

2 years ago

ACTO Secures $18M Financing to Accelerate Growth and Strengthen Position as #1 Learning Platform in Life Sciences

ACTO CXO Team (left to right): Kapil Kalra (CCO), John Schultz (CSO), Alison Muller (CMO), Parth Khanna (CEO), Kumar Erramilli…

2 years ago

EVEON announces the launch of the European project INDENEO to develop an innovative delivery system for nose to brain administration of biological and advanced therapy drugs to neonates

EVEON, designer and manufacturer of medical devices for the preparation and delivery of drugs, announces the launch of a European…

2 years ago

Calibre Scientific UK Relocates to State-Of-The-Art Facility in the Advanced Manufacturing Park, Sheffield

LOS ANGELES, July 07, 2022 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the relocation of three key UK…

2 years ago